Closed Clinical Trials
The table below contains a list of all ECOG-ACRIN clinical trials that have closed to enrollment since January 1, 2021. Note that this is not a complete listing of all closed trials. On the table below, hover over any of the column headings and click the up/down arrows to sort. You can also search by keyword. To access more information about a particular trial, click on the trial ID, which will link you to more information.
| Cancer Type | Target patient Population | Trial ID & Link to info | Study Type | ECOG-ACRIN Oversight Committee(s) |
|---|---|---|---|---|
| Any | Women with a recent cancer diagnosis | E1Q11 / EROS | Reproductive Health Planning | Cancer Control and Survivorship |
| Anus | Metastatic (advanced) | EA2165 | Treatment | Gastrointestinal |
| Blood | Acute promyelocytic leukemia (AML) | EA9131 | Treatment | Leukemia; Cancer Control and Survivorship |
| Blood | Chronic lymphocytic leukemia (CLL) | EA9161 | Treatment | Leukemia |
| Breast | Newly diagnosed, metastatic (advanced) | EAI142 | Imaging | Breast |
| Breast | Black women with breast cancer | EAZ171 | Treatment | Breast; Prevention |
| Breast | Triple negative and basal subtype, including both women and men | EA1131 | Treatment | Breast |
| Kidney | Localized (no spread) or limited spread | EA8143 / PROSPER RCC | Treatment | Genitourinary |
| Melanoma (Skin) | Melanoma, metastatic (advanced), and BRAF V600 type | EA6134 / DREAMseq | Treatment | Melanoma |
| Melanoma (Skin) | Cutaneous or unknown primary type | EA6183 | Treatment | Melanoma |
| Pancreas or Gastrointestinal Tract | Locally advanced or metastatic, inoperable | EA2142 | Treatment | Gastrointestinal |
| Prostate | Metastatic (advanced), hormone sensitive type | EA8153 / CHAARTED2 | Treatment | Genitourinary |